Neurofibromatosis type 1 (NF1), a common autosomal dominant neurogenetic disorder affecting 1 in 4000 individuals worldwide, results from functional inactivation of the 17q11.2-located NF1 gene. Plexiform neurofibroma (PNF) is a congenital benign tumour present in 30-50% of NF1 patients, which in ab
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas
β Scribed by Christiaans, I.; Kenter, S. B.; Brink, H. C.; van Os, T. A. M.; Baas, F.; van den Munckhof, P.; Kidd, A. M. J.; Hulsebos, T. J. M.
- Book ID
- 118265382
- Publisher
- BMJ Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 450 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0022-2593
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The __NF2__ gene is a putative tumorβsuppressor gene that, when it is altered in the germline, causes neurofibromatosis type 2, a tumorβsusceptibility disease that mainly predisposes to schwannomas and meningiomas. The recent isolation of the __NF2__ gene on chromosome 22 allows the ide
## Communicated by Riccardo Fodde About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumors (MPNSTs) and represent considerable patient morbidity and mortality. Elucidation of the genetic mechanisms by which inherited and acquired NF1 disease gene variant
## Abstract It is estimated that up to 35% of colorectal cancers (CRC) can be explained by hereditary factors. However, genes predisposing to highly penetrant CRC syndromes account for only a small fraction of all cases. Thus, most CRCs still remain molecularly unexplained. A recent systematic sequ